デフォルト表紙
市場調査レポート
商品コード
1679762

経カテーテル弁修復システム市場レポート:2031年までの動向、予測、競合分析

Transcatheter Valve Repair System Market Report: Trends, Forecast and Competitive Analysis to 2031


出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

経カテーテル弁修復システム市場レポート:2031年までの動向、予測、競合分析
出版日: 2025年03月13日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の経カテーテル弁修復システム市場の将来性は、病院、専門クリニック、外来手術センター市場での機会により有望視されています。経カテーテル弁修復システムの世界市場は、2025年から2031年にかけてCAGR 7.7%で成長すると予想されます。この市場の主な促進要因は、心疾患の有病率の上昇、弁疾患に対する侵襲性の低い処置に対する患者の嗜好の高まり、経カテーテル弁修復技術の継続的な進歩です。

  • 製品タイプ別では、経カテーテル大動脈弁置換術が最も高い成長が見込まれるとLucintelは予測しています。
  • 最終用途別では、病院が最も高い成長が見込まれています。
  • 地域別では、北米はヘルスケアインフラが確立されているため、予測期間中に最も高い成長が見込まれます。

経カテーテル弁修復システム市場の戦略的成長機会

経カテーテル弁修復システム市場には、主要な用途にわたって数多くの戦略的成長機会があります。これらの分野に注力することで、利害関係者は市場での地位を高め、患者ケアを向上させることができます。

  • 老人医療の拡大:高齢化人口の増加により、従来の手術では高いリスクに直面することが多い高齢患者向けに特化した経カテーテルソリューションの開発機会がもたらされます。
  • カスタマイズ可能なデバイスの開発:個々の解剖学的変化に対応したカスタマイズ可能な経カテーテルデバイスを開発することで、手技の成功率を高め、患者の転帰を改善することができます。
  • 遠隔医療との統合の増加:手術前後のケアに遠隔医療ソリューションを統合することで、患者管理を合理化し、特に地方における専門医へのアクセスを改善することができます。
  • 臨床試験の重視:経カテーテル弁修復システムの新たな用途の臨床試験に投資することで、規制当局の承認を支え、市場の受容性を高める貴重なデータを得ることができます。

こうした戦略的成長機会は、製品提供の強化、患者アクセスの改善、技術革新の促進によって経カテーテル弁修復システム市場を形成しています。これらの機会を活用する利害関係者は、進化するヘルスケア情勢における競争力を強化する可能性が高いです。

経カテーテル弁修復システム市場の促進要因・課題

経カテーテル弁修復システム市場は、技術、経済、政策におけるダイナミクスと相互作用しており、これらは促進要因としても阻害要因としても作用しています。これらの要因に関する知識は、急速に変化するこのシステムに参加しようとする利害関係者にとって重要です。

経カテーテル弁膜症治療システム市場を牽引する要因は以下の通りです:

1.心臓病の発生率の上昇:心臓疾患の発生率が増加し続けていることが、カテーテルを用いた新しい手技の需要を促進しており、市場の成長余地を十分に与えています。

2.技術の進歩:デバイス構造やデバイス材料を含むデバイス技術の向上は、経カテーテル弁治療に革命をもたらし続け、臨床医をさらに惹きつけています。

3.低侵襲治療に対する患者の嗜好:患者の知識と侵襲性の低い手技を求めるレベルの向上は、経カテーテル弁修復システム市場にプラスに寄与しています。

4.支持的な規制環境:いくつかの国では、規制当局の方針が好意的であるため、マーケットプレースにおける新規機器の承認までのスケジュールが短縮され、新しいアイデアの推進とこの分野における競争の激化に役立っています。

5.心血管研究への投資の増加:心血管研究に多くの資金が投入されることで、現在需要があり、標準治療を改善する新しい経カテーテル治療法の開発が促進されます。

経カテーテル弁修復システム市場における課題は以下の通りです:

1.処置費用の高さ:経カテーテル治療が利用できるようになると、それに伴って高額な費用が発生するため、一部の患者は治療を受けられなくなる可能性があります。

2.規制のハードル:現状の規制には肯定的な要素もありますが、新しい機器、特に新製品の開発に対する承認は複雑になる可能性があり、新製品の市場投入が遅れる原因となります。

3.既存の手術法の脅威:確立された伝統的治療法はまだ数多く存在し、これらは経カテーテル的解決策に課題するものであり、その有益性を絶えず証明する必要があります。

経カテーテル弁膜症治療システム市場では、こうした市場促進要因・課題の関係が重要です。このような外交関係があれば、利害関係者はより良い製品を作り、質の高い患者ケアを提供することができ、治療方法をより良い方向に変える助けとなると思われます。

目次

第1章 エグゼクティブサマリー

第2章 世界の経カテーテル弁修復システム市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

  • マクロ経済動向(2019~2024年)と予測(2025~2031年)
  • 世界の経カテーテル弁修復システム市場の動向(2019~2024年)と予測(2025~2031年)
  • 製品タイプ別、経カテーテル弁修復システムの世界市場
    • 経カテーテル大動脈弁置換術
    • 経カテーテル僧帽弁置換術
    • 経カテーテル肺弁置換術
    • 経カテーテル三尖弁置換術
  • 用途別、経カテーテル弁修復システムの世界市場
    • 大動脈弁狭窄症
    • 僧帽弁狭窄症
    • 三尖弁狭窄症
    • 肺動脈狭窄
  • 最終用途別、経カテーテル弁修復システムの世界市場
    • 病院
    • 専門クリニック
    • 外来手術センター
    • その他

第4章 2019年から2031年までの地域別市場動向と予測分析

  • 地域別の経カテーテル弁修復システムの世界市場
  • 北米の経カテーテル弁修復システム市場
  • 欧州の経カテーテル弁修復システム市場
  • アジア太平洋の経カテーテル弁修復システム市場
  • その他地域の経カテーテル弁修復システム市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 世界の経カテーテル弁修復システム市場の成長機会、製品タイプ別
    • 世界の経カテーテル弁修復システム市場の成長機会、用途別
    • 世界の経カテーテル弁修復システム市場の成長機会、最終用途別
    • 世界の経カテーテル弁修復システム市場の成長機会、地域別
  • 世界の経カテーテル弁修復システム市場における新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の経カテーテル弁修復システム市場の能力拡大
    • 世界の経カテーテル弁修復システム市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Abbott Laboratories
  • Medtronic
  • Boston Scientific
  • Edwards Lifesciences
  • Bracco Group
  • LivaNova
  • Meril Life Sciences
  • Sorin Group
  • Cordis
  • MicroPort Scientific
目次

The future of the global transcatheter valve repair system market looks promising with opportunities in the hospital, specialty clinic, and ambulatory surgical center markets. The global transcatheter valve repair system market is expected to grow with a CAGR of 7.7% from 2025 to 2031. The major drivers for this market are the rise in the prevalence of cardiac conditions, increasing patient preferences for less invasive procedures for valve diseases, and ongoing advancements in transcatheter valve repair technology.

  • Lucintel forecasts that, within the product type category, transcatheter aortic valve replacement is expected to witness the highest growth.
  • Within the end-use category, hospitals are expected to witness the highest growth.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period due to the presence of a well-established healthcare infrastructure in this region.

Gain Valuable Insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Transcatheter Valve Repair System Market

The transcatheter valve repair system market has various emerging trends; these include improvements in technology and changes in the way people approach their health. These trends are changing the paradigm and creating better and new gaps from which stakeholders will benefit.

  • Minimally Invasive Procedures: Procedures that do not require an incision have been on the rise in recent years. These procedures also have quicker recovery times and fewer complications, which favor both patients and healthcare practitioners. As developments in technology occur, more conditions can be treated.
  • Technological Innovations: Advancements in the design of devices, materials, and delivery systems have remained the growth drivers of the market. The developing trends include the use of biodegradable materials and improved imaging techniques, which contribute to speeding up compliance.
  • Growing Clinical Evidence: The rising clinical evidence supporting the use and effectiveness of transcatheter valve repair systems is aiding market growth. With increasing positive outcomes in clinical studies, healthcare providers are more inclined to adopt such technologies in their practice.
  • Regulatory Support: Supportive regulatory policies in several countries provide little resistance to new device approval, leading to speedy registration. It is essential that this pattern allows manufacturers to rapidly introduce new and innovative products into the market, thereby broadening the competitive landscape and providing greater diversity in treatment.
  • Increased Focus on Patient Outcomes: The trend toward patient-oriented care is affecting practice in developing transcatheter valve systems. The development of devices that allow patients to remain in the hospital for a shorter duration and enhance the quality of life for patients is likely to influence product development direction among manufacturers.

These trends are significantly impacting the transcatheter valve repair system market by emphasizing innovations, patient safety, and regulatory aid. With regard to such trends in the management of heart valve disorders, the market is likely to adapt toward development and improved strategies for these patients.

Recent Developments in the Transcatheter Valve Repair System Market

Within the transcatheter valve repair system market, several significant events are taking place that define its growth strategies. Such developments are critical in improving treatment safety and widening the scope of treatment.

  • New Device Approvals: The recently granted marketing authorizations for novel transcatheter devices, such as those by the FDA, are enhancing market optimism. Such approvals ease the entry of new devices and provide opportunities for better management techniques.
  • Enhanced Delivery Systems: Other improvements in delivery systems, such as catheter designs and access techniques, are making procedures less risky and more efficient. These improvements reduce the risk of complications and increase the success rate of the procedures.
  • Collaborative Research Initiatives: Research on transcatheter valve systems is being carried out as a result of collaboration between manufacturers and academic institutions. Joint endeavors help simplify device performance and broaden the clinical evidence regarding the application of the device.
  • Focus on Workforce Education and Training: Increased attention to training healthcare personnel in transcatheter techniques is positively affecting uptake rates. Clinicians become skilled in these advanced techniques through training programs and workshops.

These developments are crucial as they enhance the transcatheter valve repair system market by improving device efficacy, increasing the scope of applications, and providing training. As long as these developments continue in succession, the market will be in a good position for future advancements and growth in cardiovascular treatment.

Strategic Growth Opportunities for Transcatheter Valve Repair System Market

The transcatheter valve repair system market offers numerous strategic growth opportunities across key applications. By focusing on these areas, stakeholders can enhance their market position and improve patient care.

  • Expansion in Geriatric Care: The growing aging population presents opportunities to develop specialized transcatheter solutions tailored for elderly patients, who often face higher risks with traditional surgeries.
  • Development of Customizable Devices: Creating customizable transcatheter devices that cater to individual anatomical variations can enhance procedural success rates and improve patient outcomes.
  • Increasing Telemedicine Integration: Integrating telemedicine solutions for pre-and post-procedure care can streamline patient management and improve access to specialists, especially in rural areas.
  • Focus on Clinical Trials: Investing in clinical trials for new applications of transcatheter valve repair systems can yield valuable data that supports regulatory approvals and enhances market acceptance.

These strategic growth opportunities are shaping the transcatheter valve repair system market by enhancing product offerings, improving patient access, and fostering innovation. Stakeholders who leverage these opportunities will likely strengthen their competitive position in the evolving healthcare landscape.

Transcatheter Valve Repair System Market Driver and Challenges

The transcatheter valve repair system market has interacted with dynamics in technology, the economy, and policy, which have acted as both enablers and hindrances. Knowledge of these factors is important for stakeholders who wish to participate in this rapidly transforming system.

The factors responsible for driving the transcatheter valve repair system market include:

1. Rising Incidence of Heart Disease: The ever-increasing rate of occurrence of heart diseases is propelling the demand for novel catheter-based procedures, providing ample room for growth in the market.

2. Technological Advancements: Improvements in device technology, including device constructs and device materials, continue to revolutionize transcatheter valve therapy and further entice clinicians.

3. Patient Preference for Minimally Invasive Procedures: Increasing patient knowledge and levels of seeking less invasive procedures are contributing positively to the market for transcatheter valve repair systems.

4. Supportive Regulatory Environment: Favorable regulatory policies in several nations enable faster timelines for the greenlighting of novel devices in the marketplace, helping to propel new ideas and sharpen competition in the space.

5. Increasing Investment in Cardiovascular Research: As more funds are put into cardiovascular studies, this will trigger the development of new transcatheter therapies that are currently in demand and will improve the standard of care.

Challenges in the transcatheter valve repair system market are:

1. High Cost of Procedures: The availability of transcatheter procedures has associated high costs that may prevent some patients from being treated; thus, disparities in care may be observed across different populations.

2. Regulatory Hurdles: There are positive elements of regulation as it stands; however, approval for new devices, especially new product development, can be complicated, leading to delays in introducing new products into the market.

3. Threat of Existing Surgical Methods: There are still a number of traditional treatments that are well established, and these challenge transcatheter solutions, requiring continual proof of their benefits.

The relationship between such drivers and challenges is critical in the transcatheter valve repair system market. With such diplomatic relations, stakeholders will make better products and provide quality patient care, which would assist in changing treatment practices for the better.

List of Transcatheter Valve Repair System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies transcatheter valve repair system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transcatheter valve repair system companies profiled in this report include-

  • Abbott Laboratories
  • Medtronic
  • Boston Scientific
  • Edwards Lifesciences
  • Bracco Group
  • LivaNova
  • Meril Life Sciences
  • Sorin Group
  • Cordis
  • MicroPort Scientific

Transcatheter Valve Repair System by Segment

The study includes a forecast for the global transcatheter valve repair system market by product type, application, end use, and region.

Transcatheter Valve Repair System Market by Product Type [Analysis by Value from 2019 to 2031]:

  • Transcatheter Aortic Valve Replacement
  • Transcatheter Mitral Valve Replacement
  • Transcatheter Pulmonary Valve Replacement
  • Transcatheter Tricuspid Valve Replacement

Transcatheter Valve Repair System Market by Application [Analysis by Value from 2019 to 2031]:

  • Aortic Stenosis
  • Mitral Stenosis
  • Tricuspid Stenosis
  • Pulmonary Stenosis

Transcatheter Valve Repair System Market by End Use [Analysis by Value from 2019 to 2031]:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Transcatheter Valve Repair System Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Transcatheter Valve Repair System Market

The transcatheter valve repair system market is changing quickly due to technological development and a rise in patient preference for less invasive procedures. This growth is attributed mainly to places such as the United States, China, Germany, India, and Japan, where heads of health systems are directing fresh approaches to heart valve diseases, thus enhancing outcomes and access to patients.

  • United States: The U.S. market is currently undergoing rapid developments in transcatheter mitral valve repair systems, with new devices recently gaining FDA approval. Companies are investing in trials aimed at evaluating the long-term effectiveness and safety of the devices. Moreover, the growing burden of heart diseases is creating a need for less invasive techniques and therefore supporting market growth.
  • China: In China, the transcatheter valve repair system market is also growing quickly because health consciousness and acceptance of advanced cardiac treatments have increased. The government's recent efforts to improve cardiovascular healthcare infrastructure are working to ensure that these technologies are adopted more quickly. Domestic companies are joining partnerships with overseas companies to improve products and increase market share.
  • Germany: As one of the prominent countries in the field of research and development of transcatheter devices, Germany has the largest European market share in transcatheter valve repair systems. As a result of many clinical studies reporting positive outcomes with various transcatheter devices, these approaches have been embraced where possible. Moreover, the country's healthcare system is favorable for the introduction of new technologies in the field of practice.
  • India: In India, the market for transcatheter valve repair systems is growing due to better healthcare coverage and the increasing burden of heart ailments. Domestic manufacturers are developing reasonably priced products for the Indian market. Initiatives taken by the government to upgrade cardiac care systems and partnerships with international players are also helping in market growth.
  • Japan: The market in Japan has stringent regulatory requirements and places implicit reliance on regulatory quality. Market growth is on the rise due to recent approvals of new advanced transcatheter valve systems. In addition, the increasing elderly population and the rise in the prevalence of cardiovascular diseases are driving demand for effective and safe non-surgical approaches for treatment.

Features of the Global Transcatheter Valve Repair System Market

Market Size Estimates: Transcatheter valve repair system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Transcatheter valve repair system market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Transcatheter valve repair system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the transcatheter valve repair system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transcatheter valve repair system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transcatheter valve repair system market by product type (transcatheter aortic valve replacement, transcatheter mitral valve replacement, transcatheter pulmonary valve replacement, and transcatheter tricuspid valve replacement), application (aortic stenosis, mitral stenosis, tricuspid stenosis, and pulmonary stenosis), end use (hospitals, specialty clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transcatheter Valve Repair System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Transcatheter Valve Repair System Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Transcatheter Valve Repair System Market by Product Type
    • 3.3.1: Transcatheter Aortic Valve Replacement
    • 3.3.2: Transcatheter Mitral Valve Replacement
    • 3.3.3: Transcatheter Pulmonary Valve Replacement
    • 3.3.4: Transcatheter Tricuspid Valve Replacement
  • 3.4: Global Transcatheter Valve Repair System Market by Application
    • 3.4.1: Aortic Stenosis
    • 3.4.2: Mitral Stenosis
    • 3.4.3: Tricuspid Stenosis
    • 3.4.4: Pulmonary Stenosis
  • 3.5: Global Transcatheter Valve Repair System Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Transcatheter Valve Repair System Market by Region
  • 4.2: North American Transcatheter Valve Repair System Market
    • 4.2.1: North American Market by Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement
    • 4.2.2: North American Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Transcatheter Valve Repair System Market
    • 4.3.1: European Market by Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement
    • 4.3.2: European Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Transcatheter Valve Repair System Market
    • 4.4.1: APAC Market by Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement
    • 4.4.2: APAC Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Transcatheter Valve Repair System Market
    • 4.5.1: ROW Market by Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement
    • 4.5.2: ROW Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transcatheter Valve Repair System Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Transcatheter Valve Repair System Market by Application
    • 6.1.3: Growth Opportunities for the Global Transcatheter Valve Repair System Market by End Use
    • 6.1.4: Growth Opportunities for the Global Transcatheter Valve Repair System Market by Region
  • 6.2: Emerging Trends in the Global Transcatheter Valve Repair System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transcatheter Valve Repair System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transcatheter Valve Repair System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Medtronic
  • 7.3: Boston Scientific
  • 7.4: Edwards Lifesciences
  • 7.5: Bracco Group
  • 7.6: LivaNova
  • 7.7: Meril Life Sciences
  • 7.8: Sorin Group
  • 7.9: Cordis
  • 7.10: MicroPort Scientific